Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MEDP | Common Stock | Sale | -$5.64M | -26.6K | -0.46% | $211.57 | 5.81M | Dec 1, 2021 | Direct | F1, F2 |
transaction | MEDP | Common Stock | Sale | -$1.28M | -6.09K | -0.1% | $210.79 | 5.81M | Dec 2, 2021 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. |
F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $214.80. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $211.49. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |